Management of proteinuria: blockade of the renin–angiotensin–aldosterone system

Proteinuria, in particular albuminuria, is a potentially significant modifiable risk factor for cardiovascular disease and the progression of kidney disease. Current treatment guidelines for albuminuria recommend a single renin–angiotensin–aldosterone inhibitor. This can be an ACE inhibitor or an an...

Descripción completa

Detalles Bibliográficos
Autores principales: Athavale, Akshay, Roberts, Darren M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450775/
https://www.ncbi.nlm.nih.gov/pubmed/32921887
http://dx.doi.org/10.18773/austprescr.2020.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450775/
https://www.ncbi.nlm.nih.gov/pubmed/32921887
http://dx.doi.org/10.18773/austprescr.2020.021

Ejemplares similares